Short Term Results of Tele-Rehabilitation

NCT05381675 | Completed

• 1 other identifier: İntervention
• Study Type: interventional
• Target: 60
• Locations: 1 country
• Sites: 1

Brief Summary

Most people who have coronavirus disease (COVID-19) recover completely without any sequelae. However, some patients continue to experience symptoms of COVID-19 even though their tests turn negative. This clinical spectrum that occurs after acute infection is called the post-COVID syndrome (PCS). Dyspnea, pain, decreased exercise capacity, limitations in activities of daily living, poor sleep quality, anxiety and depression are common symptoms in PCS. The aim of our study is to examine the effect of tele-rehabilitation-based exercise program on dyspnea, pain, functional capacity, sleep quality, anxiety and depression in individuals with PCS.

Conditions

COVID-19; Dyspnea

Keywords

Tele-rehabilitation; COVID-19

Outcome Measures

Primary Outcomes (1)

• Change from the baseline to the 6th week in mMRC (Modified Medical Research Council) Dyspnoea Scale

  The mMRC Dyspnoea Scale is used to assess the degree of baseline functional disability due to dyspnoea

  Baseline and 6th week

Secondary Outcomes (4)

• Change from the baseline to the 6th week in NPRS

  Baseline and 6th week

• Change from the baseline to the 6th week in the 5 times sit to stand test (5XSST)

  Baseline and 6th week

• Change from the baseline to the 6th week in the Hospital Anxiety and Depression Scale

  Baseline and 6th week

• Change from the baseline to the 6th week in the The Pittsburgh Sleep Quality Index

  Baseline and 6th week

Study Arms (2)

Intervention

EXPERIMENTAL

Participants will receive a supervised tele-rehabilitation program 2 days a week for 6 weeks.

Other: Tele-rehabillitation

Control

OTHER

Participants will receive the same rehabilitation program as prescribed.

Other: Prescribed Exercise Program

Interventions

Tele-rehabillitation OTHER

Tele-rehabilitation program will be performed by physiotherapist two times a week for six consecutive weeks. Program including the following exercises: Breathing exercises Aerobic exercises Flexibility Strengthening exercises

Intervention

Prescribed Exercise Program OTHER

The prescribed exercise program will be performed two times a week for six consecutive weeks. Program including the following exercises: Breathing exercises Aerobic exercises Flexibility Strengthening exercises

Control

Eligibility Criteria

• Age: 18 Years - 75 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Being between the ages of 18-75,
• Being in stable medical condition, conscious and cooperative,
• Having had COVID and continuing symptoms
• Volunteering to participate in the study,
• Own a device that can be connected online independently or with support from family members.

You may not qualify if:

• SpO2 \< 92%,
• Hypotension (Systolic Blood Pressure \< 90 mmHg or Diastolic Blood Pressure \< 60mmHg)
• Having chronic respiratory disease (COPD, Asthma, etc.)
• Having a stroke or neurodegenerative disease.
• Not being willing to participate in the study

Sponsors & Collaborators

• Harran University: lead

Study Sites (1)

İstanbul University-Cerrahpasa

Istanbul, Turkey (Türkiye)

Location

Related Publications (1)

• Yasaci Z, Mustafaoglu R, Ozgur O, Kuveloglu B, Esen Y, Ozmen O, Yalcinkaya EY. Virtual recovery: efficacy of telerehabilitation on dyspnea, pain, and functional capacity in post-COVID-19 syndrome. Ir J Med Sci. 2025 Apr;194(2):631-640. doi: 10.1007/s11845-025-03899-3. Epub 2025 Feb 8.

  PMID: 39920519 DERIVED

MeSH Terms

Conditions

COVID-19; Dyspnea

Condition Hierarchy (Ancestors)

Pneumonia, Viral; Pneumonia; Respiratory Tract Infections; Infections; Virus Diseases; Coronavirus Infections; Coronaviridae Infections; Nidovirales Infections; RNA Virus Infections; Lung Diseases; Respiratory Tract Diseases; Respiration Disorders; Signs and Symptoms, Respiratory; Signs and Symptoms; Pathological Conditions, Signs and Symptoms

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: TRIPLE
• Who Masked: PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Research Assistant

Study Record Dates

• First Submitted: May 15, 2022
• First Posted: May 19, 2022
• Study Start: May 20, 2022
• Primary Completion: May 20, 2023
• Study Completion: August 1, 2023
• Last Updated: August 29, 2023

Record last verified: 2023-08

Locations

TU (1)